Home / Bio-technology / Global Bioreactor Market by type by Application by Regions North America Asia Pacific Market Report Forecast 2017-2021Europe Middle East & Africa and Latin America Market Report Forecast 2017-2021

Global Bioreactor Market by type by Application by Regions North America Asia Pacific Market Report Forecast 2017-2021Europe Middle East & Africa and Latin America Market Report Forecast 2017-2021

  • Id : RNR-62409
  • Category : Bio-technology
  • Publish Date : 24/03/2017
  • Pages : 123
  • Format : PDF
License Type

A bioreactor is a container which is used to hold organisms for the purpose of harnessing their natural biochemical process. They are manufactured vessels or systems that support a biologically active environment, as cells require a very specific environment to grow. These bioreactors range in size from liters to cubic meters.
Based on its types, the market is segmented into 
•	Stirred Tank Bioreactor
•	Airlift Bioreactor
•	Packed Bed Bioreactor
•	Fluidized Bed Bioreactor
•	Photo Bioreactor
•	Others
Airlift bioreactor product type accounted for major share of global bioreactors market in 2016.
By its application types, the market is segmented into 
•	Stem cells
•	T cells
•	Other mammalian cell

From the above application types, stem cell application stood as the largest and fastest growing application segment for bioreactor market in 2016 and is expected to experience growth in the near future.

The key factor responsible for this high demand is the increased consumer demand for biopharmaceuticals by consumers. Since biopharmaceuticals modulate physiological processes at the cellular level, they are effective in the treatment of disorders that are difficult to be treated by conventional pharmaceuticals. Biopharmaceuticals are currently experiencing high growth led by improved healthcare awareness, demand in developing regions, development of novel therapies such as cancer treatment, and ongoing research in developing new technology products in biotechnology and healthcare. Global bioreactor market is expected to flourish at a CAGR of 6.9% during the forecast period.
The bioreactor market is also dominated by single-use bioreactors that account for a large part of their overall use in various applications. Low upfront investment cost is the key factor that is responsible for higher usage of single-use bioreactors over fixed systems. By lowering the costs of cleaning and sterilizing bioreactors and additionally enhancing the flexibility in operations during drug manufacturing process, the adoption of single-use bioreactors results in reduced capital expenditure costs. 
The bioreactors market is experiencing significant growth in the global market, however, a major restraint that is hindering the global market growth is the lack of availability of sterilized sensor and lower volume capacity of these systems. A large number of bioreactors that are currently in use have low volume capacity since it becomes difficult for these bioreactors to maintain similar environment when up-scaled to large production capacities. Hence, this is another factor that is responsible for sluggish adoptions of these systems among end-users.
Classified by regions, the global bioreactor market is segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Bioreactors are witnessing growth in regions such as North America and Europe. However, emerging economies in Asia, Australia, and Latin America are anticipated to observe high growth in the coming years. Countries such as China, Japan, India, Southeast Asian countries, Brazil, and others are in biopharmaceutical manufacturing. A key application for bioreactor is anticipated to have a positive impact on the overall growth of bioreactors in these regions. Furthermore, biopharmaceutical and cell culture companies have been witnessing high investments owing to increased consumer demand. 
This report covers a complete analysis of the competitive landscape of the Global Bioreactor. It includes company profiles of key market players such as Thermo Fisher Scientific, Sartorius, GE Healthcare, Merck, Eppendorf and Danaher Corporation.